TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List May 23, 1980
TCL Archive In Brief: Hood to form Institute for Systems Biology, To Unite Biologists, High-Tech Industry December 17, 1999
TCL Archive Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says. December 9, 2005
TCL Archive Reimbursement: NCI, VA Begin Project On Clinical Trials Access For Veterans January 17, 1997
